Skip to content
Screener

Solventum SOLV MedSurg — Operating Expenses

Other segment segments

Dental Solutions
$141M+9.3%
Health Information Systems
$126M-1.6%

Similar metrics at other companies

Array Technologies, Inc. logo
ARRYSTI Operations — Operating Expenses
$0
Ovintiv logo
OVVCanadian Operations — Operating Expenses
$798M+34.6%
Ovintiv logo
OVVUsa Operations — Operating Expenses
$1.08B-3.6%
Employers Holdings logo
EIGInsurance Operations — Operating Expenses
$194.8M+4.3%
Sysco logo
SYYInternational Foodservice Operations — Operating Expenses
$464M+20.2%
Array Technologies, Inc. logo
ARRYArray Legacy Operations — Operating Expenses
$0

Other financials

Income statement

See full
Revenue$2.2B+2.2%
Gross profit$1.3B+9.4%
Operating income$181.0M-15.4%
Net income$92.0M+2.2%
EPS (diluted)$0.53+3.9%

Balance sheet

See full
Cash & equivalents$403.0M-18.1%
Total debt$5.8B-25.9%
Total equity$4.8B+31.7%
Total assets$14.2B-5.5%

Cash flow

See full
Operating cash flow$227.0M+34.3%
CapEx$83.0M-24.5%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$15.15B+20.6%
Enterprise value$20.54B+3.3%
P/E10.6×-22.5×
P/S1.8×+0.3×

Profitability

See full
Gross margin54.7%+0.2pp
Operating margin25%+15.7pp
Net margin17.3%+12.7pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34%+22.3pp
Debt / equity1.2×-0.9×
Current ratio-0.2×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: Solventum’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:27 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001964738-26-000047
Net Sales (Millions)Three months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Health Information Systems8291162179
Three months ended June 30,Six months ended June 30,
Operating Expenses (Millions)*2026202520262025
MedSurg$423$404$874$808
Dental Solutions141129289260
Health Information Systems126128258260
* Operating expenses are comprised of selling, general and administrative expenses and research and development expenses as shown on the condensed consolidated statements of income.
Three months ended June 30,Six months ended June 30,

Item 1. Financial Statements

FAQ

What is Solventum's medsurg — operating expenses?
Solventum (SOLV) reported medsurg — operating expenses of $423M in Q2 2026.
How has Solventum's medsurg — operating expenses changed year-over-year?
Solventum's medsurg — operating expenses increased by 4.7% year-over-year, from $404M to $423M.
What is the long-term trend for Solventum's medsurg — operating expenses?
Over 3 years (2022 to 2025), Solventum's medsurg — operating expenses has grown at a 3.6% compound annual growth rate (CAGR), from $1.44B to $1.6B.
What does medsurg — operating expenses mean?
Covers the indirect costs of running the MedSurg segment, including research and development, selling, general, and administrative expenses. This metric reflects the investment in innovation and the operational overhead required to support the segment's business activities.

Ask your AI about Solventum's medsurg — operating expenses.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude